Gerhardsson Hanna, Stalfors Joacim, Sunnergren Ola
Department of Otorhinolaryngology, Jönköping, Sweden.
Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Laryngoscope. 2025 Aug;135(8):2935-2941. doi: 10.1002/lary.32174. Epub 2025 Apr 8.
To evaluate the safety and clinical outcomes (bleeding rate, requirement for revision surgery, and patient-reported symptom relief) of pediatric cold steel tonsillotomy with or without adenoidectomy (TT/TTA).
Patients aged ≤ 18 years who underwent cold steel TT/TTA for the management of upper airway obstruction in Region Jönköping County, Sweden, between October 1, 2013, and September 31, 2023, were included in this single center, retrospective, cohort study. Data regarding postoperative bleeding and revision surgery were extracted from electronic medical records. Patient-reported outcomes were obtained from the Swedish Quality Register of Tonsil Surgery.
Among the 1810 cold steel TT/TTA procedures included in the analysis, 36 (2.0%) bleeding events were identified, comprising 12 (0.7%) and 24 (1.3%) cases involving tonsils and adenoid beds, respectively. Four (0.2%) and seven (0.4%) patients with tonsil and adenoid bleeding, respectively, required surgical intervention. No significant risk factors for postoperative bleeding were identified. The rate of revision surgery owing to regrowth of tonsil tissue or recurrent infections was 5.1%. Younger age at the time of the first surgery was a significant risk factor for revision surgery (p < 0.001). Complete (64.9%) or almost complete (29.5%) resolution of symptoms was reported in 94.4% (n = 868) of the patients 6 months postoperatively.
Cold steel TT/TTA is a safe and efficient surgical procedure for pediatric patients with upper airway obstruction owing to tonsil and adenoid hypertrophy.
评估小儿冷钢扁桃体切除术联合或不联合腺样体切除术(TT/TTA)的安全性和临床结局(出血率、再次手术需求以及患者报告的症状缓解情况)。
纳入2013年10月1日至2023年9月31日期间在瑞典延雪平郡因上气道阻塞接受冷钢TT/TTA手术的18岁及以下患者,进行这项单中心、回顾性队列研究。术后出血和再次手术的数据从电子病历中提取。患者报告的结局从瑞典扁桃体手术质量登记处获得。
在分析纳入的1810例冷钢TT/TTA手术中,确定了36例(2.0%)出血事件,其中分别有12例(0.7%)和24例(1.3%)涉及扁桃体和腺样体床。扁桃体和腺样体出血的患者分别有4例(0.2%)和7例(0.4%)需要手术干预。未发现术后出血的显著危险因素。因扁桃体组织再生或反复感染而进行再次手术的比例为5.1%。首次手术时年龄较小是再次手术的显著危险因素(p < 0.001)。术后6个月,94.4%(n = 868)的患者报告症状完全(64.9%)或几乎完全(29.5%)缓解。
对于因扁桃体和腺样体肥大导致上气道阻塞的小儿患者,冷钢TT/TTA是一种安全有效的手术方法。